Spots Global Cancer Trial Database for enoxaparin
Every month we try and update this database with for enoxaparin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® | NCT02444572 | Gastrointestina... Thromboembolic ... | Enoxaparin 4000... | 19 Years - 90 Years | Les Laboratoires des Médicaments Stériles | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin | NCT04999176 | Cancer Rivaroxaban Venous Thromboe... Thromboprophyla... | Rivaroxaban Enoxaparin | 18 Years - 89 Years | Science Valley Research Institute | |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis | NCT04462003 | Deep Vein Throm... Malignancy | Apixaban Enoxaparin | 20 Years - 80 Years | Beni-Suef University | |
| Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology | NCT01696760 | Bone Metastases Musculoskeletal... Soft Tissue Sar... Thromboembolism | acetylsalicylic... enoxaparin PCD | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke | NCT01763606 | Cancer Patients... | Enoxaparin Aspirin | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® | NCT02444572 | Gastrointestina... Thromboembolic ... | Enoxaparin 4000... | 19 Years - 90 Years | Les Laboratoires des Médicaments Stériles | |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke | NCT01763606 | Cancer Patients... | Enoxaparin Aspirin | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT | NCT00718354 | Gastric Cancer Gastroesophagea... | Enoxaparin Standard Chemot... | 18 Years - 75 Years | Thrombosis Research Institute | |
| Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles | NCT00908960 | Advanced Pancre... | Enoxaparin | 18 Years - | Dana-Farber Cancer Institute | |
| Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) | NCT03532139 | Ovarian Cancer | Enoxaparin Enoxaparin + Ro... Thromboprophyla... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients | NCT00375076 | Cancer | enoxaparin | 18 Years - | Medical University of Vienna | |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis | NCT04462003 | Deep Vein Throm... Malignancy | Apixaban Enoxaparin | 20 Years - 80 Years | Beni-Suef University | |
| Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors | NCT01965002 | Soft Tissue Neo... | MRgHIFU Aspirin Enoxaparin | 10 Years - | Stanford University | |
| Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer | NCT00426127 | Pancreatic Canc... | Docetaxel Liposomal Doxor... Enoxaparin | 18 Years - | University of Iowa | |
| Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® | NCT02444572 | Gastrointestina... Thromboembolic ... | Enoxaparin 4000... | 19 Years - 90 Years | Les Laboratoires des Médicaments Stériles | |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | NCT01444612 | Thrombosis, Ven... | dalteparin enoxaparin fondaparinux unfractionated ... | 18 Years - | GlaxoSmithKline | |
| Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity | NCT01149304 | Colorectal Canc... Liver Metastase... Irradiation Dam... Radiation Induc... | Pentoxifylline Ursodeoxycholic... Enoxaparin | 18 Years - 80 Years | University of Magdeburg | |
| Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity | NCT01149304 | Colorectal Canc... Liver Metastase... Irradiation Dam... Radiation Induc... | Pentoxifylline Ursodeoxycholic... Enoxaparin | 18 Years - 80 Years | University of Magdeburg | |
| Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer | NCT00633061 | Childhood Cance... Central Venous ... Deep Vein Throm... Catheter-relate... Catheter-relate... | Enoxaparin | - 18 Years | University of Texas Southwestern Medical Center | |
| Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) | NCT03570281 | Correction of C... | Edoxaban Enoxaparin | 20 Years - | Samsung Medical Center | |
| Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients | NCT02706249 | Venous Thormboe... | Enoxaparin | 18 Years - | Dana-Farber Cancer Institute | |
| STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis | NCT05255003 | Cancer-associat... Thrombocytopeni... | Enoxaparin Dalteparin Tinzaparin | 18 Years - | Ottawa Hospital Research Institute | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery | NCT01941602 | Meningioma | prophylactic en... non-prophylacti... | 18 Years - | St. Olavs Hospital | |
| PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | NCT01839487 | Metastatic Panc... | PEGPH20 Nab-paclitaxel Gemcitabine Dexamethasone Enoxaparin | 18 Years - | Halozyme Therapeutics | |
| STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis | NCT05255003 | Cancer-associat... Thrombocytopeni... | Enoxaparin Dalteparin Tinzaparin | 18 Years - | Ottawa Hospital Research Institute | |
| PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | NCT01839487 | Metastatic Panc... | PEGPH20 Nab-paclitaxel Gemcitabine Dexamethasone Enoxaparin | 18 Years - | Halozyme Therapeutics | |
| Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients | NCT02706249 | Venous Thormboe... | Enoxaparin | 18 Years - | Dana-Farber Cancer Institute | |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | NCT02589145 | Lymphoma | Lenalidomide Vorinostat Gemcitabine Busulfan Melphalan Rituximab Dexamethasone Caphosol Glutamine Pyridoxine Enoxaparin Stem Cell Trans... Palifermin | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
| Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) | NCT03570281 | Correction of C... | Edoxaban Enoxaparin | 20 Years - | Samsung Medical Center | |
| Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT | NCT00718354 | Gastric Cancer Gastroesophagea... | Enoxaparin Standard Chemot... | 18 Years - 75 Years | Thrombosis Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
